Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1055/s-0036-1584289 http://scihub22266oqcxt.onion/10.1055/s-0036-1584289 C4988861!4988861!27582644     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Colon+Rectal+Surg 2016 ; 29 (3): 196-204 Nephropedia Template TP {{tp|p=27582644|t=2016. Advances in Biomarkers: Going Beyond the Carcinoembryonic Antigen |pdf=|usr=}}{{27582644}} gab.com Text Advances in Biomarkers: Going Beyond the Carcinoembryonic Antigen JO: Clin Colon Rectal Surg http://www.kidney.de/pget.php?&tw=1&pmid=27582644 #FOAvip Using biologically available markers to guide treatment decisions in colorectal cancer care is becoming increasingly common, though our understanding of these biomarkers is in its infancy. In this article, we will discuss how this area is rapidly changing, review important biomarkers being used currently, and explain how the results influence clinical decision-making. We will also briefly discuss the possibility of a liquid biopsy and explore several exciting and new options. Twit Text FOAVip Advances in Biomarkers: Going Beyond the Carcinoembryonic Antigen ????Clin Colon Rectal Surg http://www.kidney.de/pget.php?&tw=1&pmid=27582644 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27582644 #FOAvip English Wikipedia <ref>{{Cite pmid|27582644}}</ref> Advances in Biomarkers: Going Beyond the Carcinoembryonic Antigen #MMPMID27582644 Lopez NE; Peterson CY Clin Colon Rectal Surg 2016[Sep]; 29 (3): 196-204 PMID27582644show ga Using biologically available markers to guide treatment decisions in colorectal cancer care is becoming increasingly common, though our understanding of these biomarkers is in its infancy. In this article, we will discuss how this area is rapidly changing, review important biomarkers being used currently, and explain how the results influence clinical decision-making. We will also briefly discuss the possibility of a liquid biopsy and explore several exciting and new options. äAdvances in Biomarkers: Going Beyond the Carcinoembryonic Antigen (epmc).pdf DeepDyve Pubget Overpricing